Next, you'll be asked to connect with Twitter. Rest assured, we will never send a tweet from your account
without your permission.
We will send you an email with an invite soon.
RT @OncLive: The continuation of bevacizumab after first progression is an effective strategy in metastatic colorectal cancer
RT @MedscapeOnc: (Colorectal Cancer) At Last! New Options for CRC Maintenance
RT @MedscapeOnc: FDA approves test for KRAS mutations in patients with colorectal cancer
See what's Trending Now for @Kailesh_RxMKT
Follow @Kailesh_RxMKT on Twitter